BDX Q4 2018 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q4 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.4B+39.0% YoY

Gross Profit

$2.1B47.5% margin

Operating Income

$571M13.0% margin

Net Income

-$135M-3.1% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$999M

Stock-Based Comp.

$61M

Balance Sheet

Total Assets

$53.9B

Total Liabilities

$32.9B

Stockholders' Equity

$21.0B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.4B	$3.2B	+39.0%
Gross Profit	$2.1B	$1.6B	+34.6%
Operating Income	$571M	$443M	+28.9%
Net Income	-$135M	$327M	-141.3%

Revenue Segments

Medical

$2.2B49%

Interventional

$1.1B26%

Life Sciences

$1.1B25%